Cellular Heterogeneity in the Level of mtDNA Heteroplasmy in Mouse Embryonic Stem Cells  by Neupane, Jitesh et al.
ReportCellular Heterogeneity in the Level of mtDNA
Heteroplasmy in Mouse Embryonic Stem CellsGraphical AbstractHighlightsd mtDNA heteroplasmy is compared in ESCs, trophectoderm
(TE), and second polar bodies (PB2)
d mtDNA heteroplasmy in ESCs ismore closely associatedwith
TE cells than PB2
d Cellular heterogeneity of homoplasmic mtDNA haplotypes
occurs at the single-cell level
d The level of mtDNA heteroplasmy increases with progressive
passage numbersNeupane et al., 2015, Cell Reports 13, 1304–1309
November 17, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.10.019Authors
Jitesh Neupane, Sabitri Ghimire,
Mado Vandewoestyne, ...,
Stijn Vansteelandt, Petra De Sutter,
Bjo¨rn Heindryckx
Correspondence
jitesh.neupane@ugent.be (J.N.),
bjorn.heindryckx@ugent.be (B.H.)
In Brief
Neupane et al. show that, in comparison
to second polar bodies, mtDNA
heteroplasmy in trophectoderm (TE) cells
is more closely correlated with the
corresponding ESCs, indicating that TE
biopsy is preferable to polar body
biopsies for pre-implantation genetic
diagnosis in mtDNA disorders. Wider
variability inmtDNA heteroplasmy in stem
cells could explain the existence of
tissues with different heteroplasmic loads
in individuals with heteroplasmic mtDNA
conditions.
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Variation in the level of mtDNA heteroplasmy in adult
tissues is commonly seen in patients with a mixture
of wild-type and mutant mtDNA. A mixture of
different mtDNA variants may influence such varia-
tion and cause mtDNA segregation bias. We
analyzed cellular heterogeneity in embryonic stem
cells (ESCs) derived from a polymorphic mouse
model containing NZB and BALB mtDNA genotypes.
In ESCs, inter-colony heterogeneity varied up to
61%, whereas intra-colony heterogeneity varied up
to 100%. Three out of five cell lines displayed nearly
homoplasmic BALB and NZB mtDNA haplotypes
in differentiated single cells. The proportion of
NZB mtDNA genotype increased with progressive
passaging (0.39%; p = 0.002). These results demon-
strate the bimodal segregation of mtDNA haplo-
types, indicating the occurrence of tissues with
variable levels of heteroplasmies in individuals with
mtDNA mutations. Furthermore, proliferation of one
mtDNA genotype over another may pose the risk of
accumulating mutant mtDNAs during subsequent
cell divisions.INTRODUCTION
Normally, all copies of mtDNA in a cell are identical (‘‘homo-
plasmy’’). However, more than one type of mtDNA variant
may exist within a cell (‘‘heteroplasmy’’). Mutation, deletion,
or depletion of mtDNA results in mtDNA disorders, which can
be lethal (Wallace, 1999). In cases of mtDNA mutation disor-
ders, a mixture of wild-type (WT) and mutated mtDNA copies
are present. Intercellular variation in the level of mtDNA hetero-
plasmy is frequently seen in individuals with heteroplasmic
mtDNA mutations. The mtDNA bottleneck followed by random
genetic drift is thought to be responsible for the unbalanced
segregation of heteroplasmic mtDNAs in the subsequent cell1304 Cell Reports 13, 1304–1309, November 17, 2015 ª2015 The Audivisions (Jenuth et al., 1996). Unlike nuclear DNA, mtDNAs
are inherited uniquely from the maternal line of origin (Al Rawi
et al., 2011; Birky, 2001). During oogenesis in the maternal
germline, there is a 1,000-fold increase in mtDNA copy
numbers from the primordial germ cells (PGCs) to the mature
metaphase II (MII) oocytes (Cao et al., 2007, 2009; Cree
et al., 2008; Monnot et al., 2013; Piko´ and Taylor, 1987; Wai
et al., 2008). If mtDNA is present in a heteroplasmic form in
the PGCs, then either of the mtDNA variants can be selected
for or against (St John, 2014), leading to intercellular variability.
In the absence of a therapeutic remedy, pre-implantation ge-
netic diagnosis (PGD) and germline genome transfer are the
only possible approaches to avoid the transmission of heritable
mtDNA disorders. However, in both cases, the potential risk of
mtDNA carryover to the offspring may result in a heteroplasmic
condition, resulting in the unbalanced segregation of mtDNA
variants.
Previous studies in heteroplasmic mouse models have
shown that one mtDNA haplotype can proliferate faster than
the other, both in mitotic (Jenuth et al., 1997; Sharpley et al.,
2012) and post-mitotic tissues (Burgstaller et al., 2014). How-
ever, the reason behind the mtDNA segregation bias is un-
known. In order to elucidate whether polymorphic mtDNA
haplotypes influence this segregation bias, we analyzed
embryonic stem cells (ESCs) and their differentiated counter-
parts in a heteroplasmic mouse model. The heteroplasmic
BALB/OlaHsd mouse model was generated as described pre-
viously (Jenuth et al., 1996) (kindly gifted by Dr. Brendan J. Bat-
tersby from FinMIT Academy of Finland Centre of Excellence,
University of Helsinki). These mice were polymorphic for two
mtDNA haplotypes coming from BALB/cByJ and NZB/OlaHsd
mouse models. These two mtDNA haplotypes differed by 101
nt (15 amino acid substitutions) (Dean et al., 2003). Using
these mouse models, we analyzed cellular heterogeneity in
the level mtDNA heteroplasmy in pluripotent and differentiated
stem cells, both in colonies and at the single-cell level. Further-
more, to test the reliability of the samples for biopsy during
PGD, we also compared the level of mtDNA heteroplasmy in
ESCs with their corresponding second polar bodies (PB2)
and trophectoderm (TE) cells originating from the same em-
bryos (Figure 1).thors
TE biopsy Heteroplasmy (%)
Blastocyst
Trophectoderm (TE) 
Inner cell mass (ICM) 
Hatching blastocyst
Second PB 
biopsy Heteroplasmy (%)
Second polar body (PB)
Pronuclei (PN)
Zygote without 
second PB
Blastocysts plated  
for ESCs derivation
Individual colony
ESC colonies 
(Pluripotency characterization) 
Retinoic-acid (RA)  
mediated differentiation  
Heteroplasmy (%)
Differentiated colonies
Inter-colony  
heterogeneity  
Pluripotent Single cells
Heteroplasmy (%)
Single cell  
heterogeneity  
Embryoid Bodies
Pluripotent single cells
Differentiated single cells
Heteroplasmy (%)
In vivo produced 
Zygote
Spontaneous differentiation
Heteroplasmy (%)
Inter-colony  
heterogeneity  
Single cell  
heterogeneity  
Figure 1. Schematic Diagram Showing the
Study Design of Cellular Heterogeneity in
the Level of mtDNA Heteroplasmy in Mouse
Embryonic Stem Cells and Their Relation
with the Corresponding Founder Embryos
Second polar bodies (PBs) were biopsied from in-
vivo-produced zygotes to measure the level of
mtDNA heteroplasmy. Zygotes (devoid of second
PBs) were cultured until blastocyst stage from
which trophectoderm (TE) cells were biopsied for
measuring mtDNA heteroplasmy. Whole blasto-
cysts (subjected to P2B and TE biopsy) were plated
to derive embryonic stem cells (ESCs). The level of
mtDNA heteroplasmy was measured in pluripotent
ESC colonies on different passages during culture
to analyze inter-colony heterogeneity (p8–p40).
Inter-colony heterogeneity was also measured in
retinoic-acid-mediated differentiated cells (p30). To
analyze intra-colony heterogeneity, single cells
from an individual pluripotent ESC colony were
recovered (p40) and the remaining cells from the
same colony were differentiated spontaneously as
embryoid bodies (EBs) for 15 days. The level of
heteroplasmy was then measured in pluripotent
and differentiated single cells. Characterization of
pluripotent stem cells is shown in Figure S1.RESULTS
TE Cells Are Informative of the Level of mtDNA
Heteroplasmy in ESCs
The survival rate of the embryos, following two biopsies, was
100% (n = 14); PB2 biopsy was done at the zygote stage and
TE biopsy on same embryo at the blastocyst stage. Heteroplas-
mic ESC lines were derived from eight embryos (57%), five of
which were used for further analysis. First, we investigated the
association between the level of mtDNA heteroplasmy in the
TE cells and that in the corresponding PB2, and we found no
evidence of association between them (R = 0.14; p = 0.64) (Table
S2). As TE cells have been shown to represent the inner cell mass
(ICM) (Treff et al., 2012) and whole blastocysts (Heindryckx et al.,
2014; Neupane et al., 2014b), the poor correlation between the
PB2 and their corresponding TE cells confirmed that polar
bodies were not reliable samples for biopsy during PGD to avoid
the transmission of pathogenic mitochondrial diseases. In terms
of coefficient of determination (R2), 4.7% of the variability in
ESCs could be attributed to a difference in PB2, whereas
19.1% was due to the difference in TE cells, indicating that the
level of mtDNA heteroplasmy in TE cells was more closely asso-
ciated with that in ESCs than in PB2 (Tables S1 and S2).
mtDNA Heteroplasmy Increases with Progressive
Passaging
Next, we analyzed the level of mtDNA heteroplasmy in undiffer-
entiated ESC colonies at different passages (n = 137) (Figure 2;
Table S1) and also in differentiated colonies (p30; n = 42) (Table
S1). Heterogeneity in the level of mtDNA heteroplasmy was
compared between individual colonies (inter-colony heteroge-Cell Repneity) within the same line in five cell lines with variable hetero-
plasmic loads. For measuring inter-colony heterogeneity, five
to ten individual colonies were randomly selected from each
line. Inter-colony heterogeneity in the proportion of NZB mtDNA
haplotype in pluripotent ESC colonies ranged from 12.2% to
21.5% in line 1, 14.0% to 49.8% in line 2, 14.7% to 54.5% in
line 3, 19.3% to 61% in line 4, and 13.1% to 39.9% in line 5 (Table
S1). Interestingly, the proportion of mean NZB mtDNAs
increased from 65.8% to 88.7% in line 1, 45.8% to 54.9% in
line 2, 47.0% to 64.1% in line 3, 79.2% to 86.9% in line 4, and
90.1% to 92.4% in line 5 (Figure 2; Table S1). The statistical anal-
ysis revealed a strong evidence of an increase in the NZBmtDNA
haplotype with each passage (mean increase per passage
0.39%, p = 0.002) (Figure 2; Table S1).
In order to investigate if the ESCs exhibit segregation bias after
differentiation, we analyzed the level of mtDNA heteroplasmy in
differentiated colonies (RA-mediated differentiation on p30) from
each ESC line. In differentiated cells, inter-colony heterogeneity
varied by 7.6% in line 1, 45.3% in line 2, 27.4% in line 3, 1.5% in
line 4, and 45.2% in line 5 (Table S1). However, no evidence of
the difference in the level of heteroplasmy between differentiated
and undifferentiated cells (mean difference 0.72, p = 0.74) in
the ESC colonies was observed.
Single-Cell Heterogeneity Displayed a Homoplasmic
State for mtDNA Haplotypes
Given that each ESC colony comprises hundreds of single cells,
we aimed to investigate if individual cells within a colony exhibit
difference in the proportion of mtDNA haplotypes. For this, het-
erogeneity at the single-cell level in pluripotent (n = 79) and differ-
entiated (n = 107) ESCs was studied. We analyzed 15–22 singleorts 13, 1304–1309, November 17, 2015 ª2015 The Authors 1305
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Figure 2. Variation in the Level of mtDNA Haplotypes as a Function
of Passage, Shown in Five Different Cell Lines
Level of mtDNA heteroplasmy (% of NZB mtDNA haplotype) was measured in
five to ten pluripotent ESC colonies from cell lines 1 (black), 2 (red), 3 (green),
4 (blue), and 5 (cyan) on passages 8, 12, 30, and 40. The mean NZB haplotype
proportion increased from 65.8% to 88.7% in line 1, 45.8% to 54.9% in line 2,
47.0% to 64.1% in line 3, 79.2% to 86.9% in line 4, and 90.1% to 92.4% in
line 5. The proportion of NZB mtDNA haplotype in the pluripotent ESCs
increased by 0.39%per passage during culture (p = 0.002). Data are presented
in Table S1. A schematic diagram showing the heteroplasmic load measure-
ment is shown in Figure S2.
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Figure 3. Boxplots Showing Variation in the Proportion of NZB and
BALB mtDNA Haplotypes in Undifferentiated and Differentiated
Embryonic Stem Cells in Five Cell Lines
Single-cell analysis displayed homoplasmic states for mtDNA haplotypes in
three cell lines (L1, L4, and L5) before and/or after differentiation. In undiffer-
entiated single cells (yellow), homoplasmic NZB mtDNA was observed in cell
lines 1, 4, and 5. In differentiated single cells (green), homoplasmic states for
both the mtDNA haplotypes were observed in cell lines 1 and 5, whereas a
homoplasmic state for NZB mtDNA was observed in cell line 4 (Table S1). A
standard curve showing the detection limit and the efficiency of heteroplasmic
load measurement is shown in Figure S3 (Table S3). UD, undifferentiated; D,
differentiated; L, cell line.cells randomly selected from one colony from each cell line,
before and after differentiation, originating from the same colony.
The proportion of NZB mtDNA haplotype in pluripotent single
cells varied from 59.9% to 100% in line 1, 30.8% to 79.9% in
line 2, 16.7% to 96% in line 3, 69.4% to 100% in line 4, and
59.8% to 100% in line 5 (Table S1). In pluripotent single cells,
the level of heteroplasmy varied by 36% on average (Figure 3;
Table S1).
We further investigated whether the difference in the propor-
tion of NZB and BALB mtDNA haplotypes observed at the sin-
gle-cell level in the pluripotent state varied after differentiation.
For this purpose, we analyzed the proportion of mtDNA haplo-
types present in single ESCs after spontaneous differentiation
by forming embryoid bodies (EBs). Much wider variation in the
proportion of mtDNA haplotypes was observed in differentiated
single cells, demonstrating homoplasmic haplotypes for both
NZB and BALB mtDNA (Figure 3; Table S1). The statistical anal-
ysis showed a significant difference in the level of mtDNA heter-
oplasmy between pluripotent and differentiated single cells1306 Cell Reports 13, 1304–1309, November 17, 2015 ª2015 The Au(mean difference = 8.5%; p = 0.0014). The proportion of NZB
mtDNA haplotype in differentiated single cells varied from 0%
to 100% in line 1, 18.4% to 65.8% in line 2, 20.3% to 61.5% in
line 3, 7% to 100% in line 4, and 0% to 100% in line 5 (Figure 3;
Table S1). When these single cells were grouped into different
categories as <30%, <30%–70%, and >70%, more than half
(53%) of the analyzed single cells showed segregation toward
NZB haplotype (Table S1). Slightly more than one-third (34%)
of the cells showed bidirectional segregation, and nearly one-
eighth (13%) of the cells showed affinity toward the BALB
mtDNA haplotype. However, no statistical difference was
observed in mtDNA heteroplasmy levels between single cells
and their corresponding colonies obtained from the same pas-
sage (p40) (p = 0.21) (Table S1).
DISCUSSION
In this study, first we compared the level of mtDNA heteroplasmy
in PB2, TE cells, and their corresponding ESCs in heteroplasmic
mouse models. We then analyzed cellular heterogeneity at the
stem cell level, both in pluripotent and differentiated states. Paull
et al. (2013) have investigated themtDNA heterogeneity in plurip-
otent and differentiated stem cells to detect the re-emergence of
heteroplasmic mtDNA after germline nuclear transfer, if any, in
humans. While the transmitted mtDNA was detected at very
low levels (<1%) initially, no detectable mtDNA heteroplasmy
was observed in the isolated stem cell lines, even after extensive
passaging or differentiation (Paull et al., 2013). They investigated
heterogeneity in stem cell colonies derived from single cells andthors
also in each of the germ layers after differentiation, unlike our
study, where we assessed the mtDNA heteroplasmy in single
cells from pluripotent stem cell colonies and EBs in a heteroplas-
mic mouse model.
In line with the current study where we observed a poor corre-
lation between PB2 and TE cells, previous studies have also
reported a poor correlation between PBs and oocytes or blasto-
meres (Gigarel et al., 2011; Vandewoestyne et al., 2012) and a
strong correlation between TE cells and inner cell mass (Treff
et al., 2012) or blastocysts (Heindryckx et al., 2014). The poor
correlation between PB2 and TE cells could be due to at least
two factors: (1) random genetic drift may lead to unbalanced dis-
tribution of mtDNA haplotypes during successive cell divisions in
the embryos (Jenuth et al., 1996), and (2) biased inheritance of
mtDNA haplotypes during asymmetric cell division in the pre-
implantation embryos may cause variation in the proportion of
mtDNA haplotypes in the daughter cells (Dalton and Carroll,
2013).
Unlike previous studies that have shown unidirectional loss of
mtDNA heteroplasmy in the pluripotent stem cells (PSCs) during
in vitro culture (Cherry et al., 2013; Folmes et al., 2013), we did
not observe such a phenomenon. The bimodal variation in the
level of mtDNA heteroplasmy, observed in the current study, to
either the BALB homoplasmic state or NZB homoplasmic state
at the single-cell level could be due to asymmetric mtDNA trans-
mission during subsequent cell divisions. In line with our study,
Ha¨ma¨la¨inen et al. (2013) demonstrated bidirectional segregation
of mtDNAs in induced PSCs toward WT or mutant homoplasmy,
indicating no clear selection for or against mutant m.3243A > G
mtDNA upon reprogramming (Ha¨ma¨la¨inen et al., 2013).
Tissue-specific variability with bimodal segregation of poly-
morphic mtDNA variants was reported in the earlier studies in
heteroplasmic mouse models (Jenuth et al., 1997; Sharpley
et al., 2012). However, directional loss of mtDNA variants was
seen in the mitotic tissues in these mice, resulting in tissue-spe-
cific variability. A recent study in heteroplasmic mouse models
demonstrated mtDNA segregation bias in post-mitotic tissues
within the same subspecies and showed a prenatal segregation
pattern (Burgstaller et al., 2014). They showed that mtDNA
segregation bias could occur in polymorphic mouse models
with an admixture ofmtDNA haplotypes. After analyzing interme-
diate to high heteroplasmic ESC lines in the current study, our
results demonstrated the proliferation of the NZB mtDNA haplo-
type during progressive passage of pluripotent ESCs, irrespec-
tive of the original mtDNA proportion. The mechanism by which
heteroplasmic mtDNA segregation bias occurs is unknown. It
might be possible that one mtDNA haplotype is selected against
another (Burgstaller et al., 2014); however, there is no proof to
support this phenomenon, and it could vary in different models.
A recent study by our group demonstrated the divergent
mutant load distribution in peripheral blood mononuclear cells
(PBMCs), ranging from homoplasmic WT (0%) to nearly homo-
plasmic mutant (95%) mtDNA variants in a patient with an
m.3243A > G (MELAS) point mutation (Vandewoestyne et al.,
2011). Implying such tremendous variability at the single-cell
level in ESCs and PBMCs, we speculate that embryos with var-
iable mutation loads could be screened during PGD in individ-
uals with heteroplasmic mtDNA mutations. This could provideCell Repan opportunity for fertility clinics to search for mutation-free em-
bryos to prevent the transmission of pathogenic mtDNA muta-
tions, as was reported in our previous study (Heindryckx et al.,
2014). From an ethical perspective, if an mtDNA mutation could
be managed by a PGD approach by selecting and transferring
mutation-free embryos (or those with undetectable mutant
loads), it would avoid the use of donor oocytes/embryos, thereby
avoiding the involvement of a third parent, which is required for
germline nuclear transfer techniques (Craven et al., 2010; Neu-
pane et al., 2014a; Tachibana et al., 2013).
The heterogeneous distribution ofmtDNA heteroplasmy in sin-
gle cells is in concordance with the previous studies showing
variability in mtDNA heteroplasmy in organs of adult mice toward
either of themtDNA genotypes, indicating that the segregation of
polymorphicmtDNAsmay not be neutral (Burgstaller et al., 2014;
Jenuth et al., 1997; Sharpley et al., 2012). However, a striking dif-
ference may exist between germline and somatic cell mtDNA
heteroplasmy segregation as reported by Sharpley and col-
leagues (2012). Furthermore, passage-associated increase in
NZB mtDNA haplotype during in vitro cell culture was irrespec-
tive of the original mtDNA proportion, showing the unbalanced
proliferation of a heteroplasmic mtDNA genotype. Proliferation
of mtDNA genotypes has been associated with the difference
in mtDNA genotypes, with proportional increment correspond-
ing to distant genetic haplotypes (Burgstaller et al., 2014).
Furthermore, proliferation of one mtDNA genotype could be
linked with the selective advantage over another in some tissues,
resulting in tissue-specific segregation (Takeda et al., 2000).
However, such a selection might be influenced by the in vivo
or in vitro state of the cells. Battersby and Shoubridge (2001) re-
ported the selective advantage of NZB mtDNAs over BALB
mtDNAs in mouse liver cells in vivo. However, isolation and
in vitro culture of hepatocytes from the livers of same heteroplas-
mic mice reversed the segregation direction, enriching BALB
mtDNAs (Battersby and Shoubridge, 2001), which indicates
that growth medium might influence the segregation bias. An in-
crease in level of NZB mtDNA in the current study might be due
to the influence of in vitro culture, which needs further investiga-
tion in vivo. Nevertheless, the mechanism and direction of
segregation might be due not to a difference in replication rate
between two genotypes but to themaintenance of mitochondrial
genome or mitochondrial turnover (Battersby and Shoubridge,
2001; Wallace and Chalkia, 2013).
The present study points out the risk of mtDNA segregation
bias at the stem-cell level, which may occur if the embryo
selected for PGD is not mutation-free or if the mtDNA carryover
after meiotic nuclear transfer is not undetectable. However, re-
sults from animal models should be cautiously extrapolated to
humans, since the species-specific difference in mtDNA segre-
gation between mouse models and humans cannot be ignored.
Moreover, polymorphic mtDNA may segregate differently than
mutant mtDNA. Therefore, to avoid the concern of limited mea-
surements and animal models, more studies should be conduct-
ed with bigger sample sizes to confirm these results in human.
We report cellular heterogeneity in the ESCs in amousemodel
with different mtDNA haplotypes, along with the relation be-
tween ESCs and their founder embryos (PB2 and TE). Selective
proliferation of one mtDNA haplotype over another may result inorts 13, 1304–1309, November 17, 2015 ª2015 The Authors 1307
the potential amplification of mutant mtDNA with aging, as dis-
cussed recently (Ye et al., 2014). Furthermore, wider heteroge-
neity observed in differentiated single cells corresponds with
the tissue-specific variability in the levels of heteroplasmies in
individuals with mtDNA mutations. However, further studies
are required to explore the germ layer specific segregation of
mtDNA.
EXPERIMENTAL PROCEDURES
Embryo Collection and Micromanipulation
In-vivo-fertilized zygotes were collected from superovulated heteroplasmic
BALB/cOlaHsd female mice, which contained the mtDNA mixture of BALB/
cByJ and NZB/OlaHsd strains. PB2 were biopsied from zygotes, and the re-
maining zygote was cultured in potassium simplex oxidized medium (KSOM)
until the morula stage and subsequently in Cook Blastocyst medium until
the blastocyst stage. TE cells were biopsied from hatching blastocysts, and
the remaining blastocyst was used for ESC derivation (Figure 1; Figure S1).
ESC Derivation and Differentiation
Mouse ESCs were derived as described elsewhere (Ghimire et al., 2015). For
inducing differentiation, ESCs were cultured in N2B27 medium containing
1 mM retinoic acid (RA) for 7 days (without 2i and leukemia inhibitory factor
[LIF]). For spontaneous differentiation, cells were plated in low-attachment
24-well plates in N2B27 medium (without 2i and LIF) for 15 days to form EBs.
Polymerase Chain Reaction Restriction Fragment Length
Polymorphism
Isolated TE cells and ESCs were transferred to separately labeled micro-
centrifuge tubes (Westburg) containing 10 ml PicoPure DNA extraction buffer
with proteinase K (PicoPure DNA extraction kit, Arcturus). All samples were
incubated at 65C for 3 hr, centrifuged briefly, and heated at 95C for 10 min
to inactivate proteinase K. PCR restriction fragment length polymorphism
(RFLP) was used to measure the level of mtDNA heteroplasmy in the different
stages of embryos and ESCs (Figures 1 and S2). Nested PCR was performed
to amplify mtDNAs from single ESCs. First PCR amplification was performed
using the forward primer NPMT9 (50-ATATCAATTTACCAGAACTCTAC-30), an-
nealing the mitochondrial genome from nucleotides 3,493 to 3,515, and the
reverse primer NPMT10 (50-CCTAGTTGTTTATAGTTGAGTAC-30), annealing
the mitochondrial genome from nucleotides 4,157 to 4,135. Second PCR
amplification was performed using the 6-fluorescein amidite (6-FAM)-labeled
forward primer MT9 (50-GAGCATCTTATCCACGCTTCC-30), annealing the
mitochondrial genome from nucleotides 3,571 to 3,591, and the reverse primer
MT10 (50-CTGCTTCAGTTGATCGTGGGT-30) (labeled with (1-naphthyl) ethyle-
nediamine dihydrochloride [NED]), annealing the mitochondrial genome from
nucleotides 4,059 to 4,079 (Tables S4 and S6).
After restriction digestion, heteroplasmic amplicons were cleaved into a
6-FAM-labeled 121-bp fragment (exclusively coming from BALB mtDNA), an
NED-labeled 170-bp fragment (common for NZB and BALB mtDNA), and a
6-FAM-labeled 339-bp fragment (exclusively coming from NZB mtDNA).
Capillary Electrophoresis and Calculation of Heteroplasmic Load
The amplified mtDNA fragments were analyzed by capillary electrophoresis
using an ABI 3130 Genetic Analyzer (Applied Biosystems). The heteroplasmic
load (proportion of NZBmtDNA) was determined by calculating the ratio of the
area of the 6-FAM labeled 339-bp fragment and the sum of the areas of the
6-FAM 339-bp fragment and the 6-FAM 121-bp fragment, multiplied by 100
(Figure S2). Heteroplasmic load below 2% was considered undetectable.
Relation between input and output heteroplasmy has been shown in Figure S3
(Table S3).
Statistical Analysis
The analysis of the embryonic stem cells was based on linear mixed models to
account for (random) line effects. The multivariate model included linear
effects of differences between differentiated and undifferentiated cells. It1308 Cell Reports 13, 1304–1309, November 17, 2015 ª2015 The Aumoreover allowed for the variability in the level of heteroplasmy to change
over passages. Marginal residual plots confirmed the adequacy of the final
models. Statistical analyses were performed in RStudio version 0.97.320
and Microsoft Excel. p values below 0.05 were considered significant.
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